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Abstract
Background: Bovine herpesviruses type 1 (BoHV1) and type 5 (BoHV5) are two closely related
pathogens of cattle. The identity of the two viruses on the amino acid level averages 82%. Despite
their high antigenetic similarities the two pathogens induce distinctive clinical signs. BoHV1 causes
respiratory and genital tract infections while BoHV5 leads to severe encephalitis in calves.
Findings: The viral genomes of BoHV1 and BoHV5 were cloned as infectious bacterial artificial
chromosomes (BACs). First, recombinant viruses carrying the genetic elements for propagation in
bacteria were generated. Second, DNA from these recombinant viruses were transferred into
prokaryotic cells. Third, DNA from these bacteria were transferred into eukaryotic cells. Progeny
viruses from BAC transfections showed similar kinetics as their corresponding wild types.
Conclusion: The two viral genomes of BoHV1 and BoHV5 cloned as BACs are accessible to the
tools of bacterial genetics. The ability to easily manipulate the viral genomes on a molecular level
in future experiments will lead to a better understanding of the difference in pathogenesis induced
by these two closely related bovine herpesviruses.
Findings
Background and aim of this study
Bovine herpesviruses type 1 (BoHV1) and type 5 (BoHV5)
belong to the subfamily Alphaherpesvirinae and are closely
related pathogens of cattle, with coding capacity of more
than seventy open reading frames (ORF's) [1]. Despite
their high identity (82%) on the amino acid (aa) level
leading to a similar antigenetic repertoire [2], these two
viruses induce distinctive clinical signs. BoHV1 causes res-
piratory and genital tract symptoms including infectious
rhinotracheitis, pustular vulvovaginitis, and abortion [3].
BoHV5 causes severe encephalitis in calves and experi-
mentally in rabbits and mice [4-7]. In order to have an
approach to elucidate the differences in the pathogenesis
of these two viruses on a molecular level, we have set out
to clone the entire genomes of BoHV1 (strain Jura) and
BoHV5 (strain N569) as bacterial artificial chromosomes
(BACs). As such, these cloned genomes will become acces-
sible to the tools of bacterial genetics [8], allowing facili-
tated generation of recombinant viruses in future
experiments. In fact, BoHV1 genomes of three different
strains were previously cloned as BACs by Mahony et al.
(strain V155) [9], Trapp et al. (strain Schönböken) [10],
and Liu et al. (strain Cooper) [11]. However, in contrast to
the approach reported by Mahony et al. and Trapp et al.,
we introduced the heterologous sequences flanked by loxP
sites into a intergenic region of BoHV1 genome. The ben-
efit of this strategy is given by the fact that none of the viral
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DNA coding sequences are disrupted. The heterologous
sequences can be excised on demand by Cre recombinase,
which depicts another advantage over the previously used
methods. Unlike the construct of Mahoney et al. [9] our
BoHV1 BAC clone harbours GFP coding sequence as part
of the heterologous sequences, which easily enables the
monitoring of virus plaque formation using fluorescent
microscopy. The BoHV1 BAC reported by Liu et al. [11]
has similar genetic features as our BoHV1 BAC though we
cloned the strain we investigated most in our lab and we
report the cloning of BoHV5 as BAC, which is not reported
yet.
The cloning of BoHV genomes as BACs can be divided
into three steps: First, genetic elements required for DNA
replication and selection in bacteria were inserted by
homologous recombination into the virus genomes. Sec-
ond, circular viral DNA was extracted from infected cells
and transferred into bacteria. Third, viruses were reconsti-
tuted upon transfection of BAC-DNA into eukaryotic cells.
Generation of recombinant viruses in eukaryotic cells
To generate recombinant (r) BoHV viruses carrying the
BAC cassette, eukaryotic cells were cotransfected with viral
DNA of BoHV1 or BoHV5 with appropriate plasmids,
which allow the insertion of heterologous elements into
the viral genomes over homologous recombination. The
viral DNAs used for cotransfections were isolated from
sucrose cushion (12 ml 35% in TNE) purified virions (col-
lected from one infected 150 cm2 tissue culture flask) by
SDS (1%) and Proteinase K (0.6 g/l) treatment and phe-
nol/chloroform extraction. In order to construct the plas-
mid used for cotransfections with BoHV1 DNA (pBS-
Belo-BoHV1), sequence elements necessary for replica-
tion and selection of DNA in bacteria and eGFP under the
control of the Cytomegalovirus Immediate Early (CMV-
IE) promoter as a reporter protein were flanked by two
loxP sites and on each side a stretch of BoHV1 specific
DNA sequences allowing homologous recombination
with viral DNA [12,13]. Two NsiI sites just outside the loxP
sites were introduced into the plasmid pBS-Belo-BoHV1
and its sequence was deposited in GenBank (accession
number AY665170). These NsiI sites were used for
exchange of the BoHV1 specific sequences with the
BoHV5 specific sequences resulting in the plasmid pBS-
Belo-BoHV5. Recombinant (r) BoHV1, carrying the BAC
cassette, was generated in Madine Darby Bovine Kidney
cells (MDBK cells) (50% confluent on 60 mm plates)
cotransfected with 4.5 μg BoHV1 strain Jura DNA and 1 μg
pBS-Belo-BoHV1, and 0.5 μg of plasmid pBCMV26 by
BES buffered CaCl2 precipitation method [14]. Likewise,
rBoHV5 was generated in Vero 2-2 cells (1.2 × 106 on 60
mm plate) cotransfected with 2 μg BoHV5 strain N569
DNA and 0.2 μg pBS-pBelo-BoHV5 and 0.2 μg of plasmid
pBCMV26 by Lipofectamin (Invitrogen) [15]. The recom-
bination cassette was targeted to a noncoding region of
the viruses, which is located between the UL54 ORF
(encoding BICP27) and the neighboring ORF encoding
the circ protein (Figure 1A). Plasmid pBCMV26 [16]
encoding for the Bovine infected cell protein 0 (BICP0)
gene under the control CMV-IE was included in the
cotransfection to increase the infectivity of transfected
BoHV1 DNA (Fraefel, unpublished results). Both,
rBoHV1 and rBoHV5 carrying BAC cassettes and express-
ing the enhanced green fluorescent protein were plaque
purified in three consecutive rounds on MDBK cells under
DMEM supplemented with 0.75% agarose.
Transfer and propagation of viral DNA in bacteria
A typical feature of herpesvirus genomes is their circular
conformation early in infection [17]. Since circularity of
DNA is a prerequisite for the propagation of plasmids in
bacteria, such DNA was isolated from infected cells. In
brief, confluent MDBK cells grown in 60 mm plates were
infected at a multiplicity of infection (moi) of 5 with
rBoHV1 or rBoHV5. Two (rBoHV1) or four (rBoHV5)
hours post infection (hpi) the monolayer was washed
once with PBS, then rinsed using 10 mM EDTA, 10 mM
Tris-HCI, pH 8.0 buffer, subsequently the cells were
scraped from the tissue culture dish into 0.7 ml of the
same buffer. Proteinase K and SDS were added to final
concentrations of 0.25 g/l and 0.6%, respectively. Three
microliters of circular viral DNA were taken to electropo-
rate E. coli (ElectroMAX™ DH10B™, Invitrogen) using 0.1
cm-cuvettes in a BioRad Gene Pulser (1.8 kV voltage, 200
Ω impedance, 25 μF capacity). The electroporated bacteria
were grown on Luria-Bertani (LB)-plates supplemented
with 12.5 μg/ml chloramphenicol. Colonies were picked
and expanded in liquid LB medium supplemented with
12.5 μg/ml chloramphenicol.
DNA was extracted from bacterial cultures and analysed
by restriction enzyme analysis. The resulting BACs were
designated fBoHV5 BAC and fBoHV1 BAC, respectively.
The restriction enzyme patterns confirmed the integrity of
the viral DNA and the insertion of the replicon sequence
at the desired location (Figure 1A to 1B). Of note, the
unique short segment (US) of the genome did not invert
relative to the long segment (UL) in the BAC DNA. The
herpes-genomic DNA as part of the BACs were frozen in
the following isomeric arrangement: UL  (circ through
BICP0), internal repeat, US (US1.67 through US9), termi-
nal repeat (Figure 1C).
Viral growth curve analysis
Furthermore, we wanted to address the question whether
the insertion of 8.5 kb heterologous DNA sequence in
BoHV genomes influences viral replication in vitro? ToBMC Research Notes 2009, 2:209 http://www.biomedcentral.com/1756-0500/2/209
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Strategy for cloning the full-length genomes of wt BoHV5 and wt BoHV1 as BACs and restriction enzyme analyses (REA) Figure 1
Strategy for cloning the full-length genomes of wt BoHV5 and wt BoHV1 as BACs and restriction enzyme 
analyses (REA). Panel A: Restriction maps of BoHV5 (BamHI; left) and BoHV1 (HindIII; right). Division in unique long (UL), 
unique short (US), internal repeat (IR) and terminal repeat (TR) is shown on top, fragments are lettered alphabetically and sizes 
are indicated in kbp. Left ends of genomes are additionally blown up to map the site of BAC backbone insertion between CIRC 
(circ) and BICP27 (27). Upon insertion into BoHV5, BamHI fragment A is replaced by fragments A1, A2, and A3. Likewise, 
insertion into BoHV1, HindIII fragment N is replaced by fragments N1, N2 and N3. Panel B: Restriction enzyme digests of wt 
BoHV, rBoHV, fBoHV and rBoHVΔBAC. Fragments of interest are labelled as in panel A: Panel C: Possible two orientations 
of US within fBoHV5 and fBoHV1 respectively. HindIII map of both orientations for BoHV1 is part of panel A, NdeI of both ori-
entations for BoHV5 is given above the REA. fBoHV5 BAC #5 and fBoHV1 BAC #3 pointed with red circles were used for fur-
ther experiments.BMC Research Notes 2009, 2:209 http://www.biomedcentral.com/1756-0500/2/209
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answer this question viral growth curve analyses were per-
formed. MDBK cells were infected with respective viruses
at multiplicity of infection (moi) of 0.01. After 2 h at 4°C,
the temperature was shifted for 1 h to 37°C to allow virus
penetration. The inoculum was removed, the cells were
washed twice with PBS and overlaid with fresh DMEM.
Immediately thereafter (time 0), and after 24, 48, 72, and
96 h of incubation at 37°C, the infected cells were scraped
into the cell culture medium and clarified by centrifuga-
tion (311 × g for 10 min). The supernatant was removed
and analyzed separately, the cell pellet was resuspended
in fresh DMEM. Infectious virus was harvested following
three cycles of freezing/thawing and low speed centrifuga-
tion to remove cell debris. The amount of infectious virus
in the supernatants as well as in the pellets was deter-
mined by separate titration assays in 96 well plates. Each
titration was performed in three independent experiments
and viral titers were determined as TCID50/ml in MDBK
cells (Figure 2).
Briefly, the growth curves and the final titers were similar
for all viruses, although wt BoHV5 and rBoHV5 reached
generally, though not significantly, higher titers than wt
BoHV1 and rBoHV1 mutant. Furthermore, the amounts
of cell-free virus slightly exceeded the amount of cell-asso-
ciated virus. However, the viruses with retained BAC cas-
sette had similar kinetics to the respective wt BoHV
viruses.
Growth kinetics of rBoHV5 and rBoHV1 mutants versus wt BoHV5 and wt BoHV1 Figure 2
Growth kinetics of rBoHV5 and rBoHV1 mutants versus wt BoHV5 and wt BoHV1. MDBK cells were infected at 
moi of 0.01 PFU with different viruses and harvested at various times post inoculation as indicated. The virus yields at each 
time point were determined by titration. Panels A and B: wt BoHV5 (full squares) and rBoHV5 (open squares). Panels C 
and D: wt BoHV1 (full circles) and rBoHV1 (open circles). Cell-free (supernatant, panels A and C) and cell-associated virus 
(pellets, panels B and D) were titrated separately. The x-axis represents the time scale post infection. Virus titers (y-axis) are 
expressed as TCID50/ml.
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Deletion of BAC cassettes in rBoHV's by cre mediated 
recombination
MDBK cells were cotransfected with rBoHV1 or rBoHV5
viral DNA and a Cre  recombinase expressing vector
p116.006 [18]. Three days post transfection five viral
plaques were randomly collected and plaque purified
three times as described above. Finally, viral DNA from
non-eGFP fluorescent progeny was extracted and charac-
terized by restriction enzyme analysis in order to verify the
deletion of the BAC. Upon reconstitution of BAC DNA,
Unique short (US) segment does again invert relative to
Unique long (UL) segment (Figure 1B).
In conclusion, our results describe the successful cloning
of both, the BoHV5 and BoHV1 genome as BACs. Upon
transfection of MDBK cells with BoHV5 or BoHV1 BAC
DNA green fluorescent plaques were generated (Figure 3).
The BAC cassettes were successfully deleted upon co-
transfection of MDBK cells with BoHV5 BAC DNA or
BoHV1 BAC DNA and Cre recombinase expressing vector,
resulting in black viral plaques formation. The viral repli-
cation kinetics of BAC derived viruses was not altered
through insertion of 8.5 kb heterologous DNA as they rep-
licated similar to their respective wild types. Indeed, pre-
liminary experiments indicate (data not shown) that the
rescued viruses did retain their virulence, at least in a pre-
viously described mouse model [4]. Thus, the overall
properties of wt and rescued viruses are well preserved in
the BAC. This is important since BoHV5 isolates may
attenuate rapidly upon passaging in cell cultures. In con-
trast, BoHV1 and BoHV5 genomes frozen in BACs remain
very stable.
Thus, these cloned genomes will be useful tools towards
elucidating the differences in the pathogenesis of BoHV1
and BoHV5, using bacterial genetics for genome manipu-
lation [8].
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